TEMPUS AI INC-CL A

TEM stock refers to the publicly traded shares of Tempus AI, Inc., a healthcare technology company listed on the Nasdaq exchange under the ticker TEM. The company focuses on applying artificial intelligence and data analytics to precision medicine, particularly in oncology. Its platform connects genomic data, clinical data, and real-world evidence to help physicians and researchers make more informed treatment decisions. TEM shares give investors exposure to the intersection of AI and healthcare.

TEM shares can be influenced by developments in artificial intelligence and precision medicine, quarterly financial results, regulatory approvals, clinical partnerships, and adoption of its genomic testing platform. Broader market sentiment toward high-growth technology and healthcare stocks also matters, as do changes in reimbursement policies. Interest rates and macroeconomic conditions can affect valuations of companies with long-term growth profiles. Company-specific news, such as collaborations or data releases, may also move the stock.

The latest price of TEM stock is displayed in real time on this page, along with intraday changes and other market data. Stock prices fluctuate continuously during trading hours, so the most accurate figure is the one shown in the quote section above. For historical closing prices or after-hours quotes, refer to the chart and market data panels provided on this page.

Whether TEM stock appears overvalued or undervalued depends on the valuation metrics and assumptions used, and no single measure is definitive. Investors often examine price-to-sales, price-to-book, and enterprise value ratios relative to peers and growth expectations. Since TEM operates in a rapidly evolving field, factors such as revenue growth, margins, and future cash flow potential are also relevant. Current valuation data and comparisons are available on this page.

TEM shares may be available for trading in pre-market and after-hours sessions on U.S. exchanges, though liquidity is typically lower and spreads can be wider than during regular hours. Extended-hours trading carries additional risks, including price volatility and limited order types. Not all brokers offer this feature, so investors should confirm availability and any associated fees with their brokerage. Regular market hours remain the most liquid period for TEM.

Tempus AI, Inc. does not currently pay a dividend on its common stock. As a growth-oriented healthcare technology company, it typically reinvests earnings into research, product development, and expansion rather than returning capital to shareholders. Dividend payments are not part of its current capital allocation strategy. Investors seeking income may want to review the latest company disclosures for any future changes to this policy.